Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Plexxikon CEO: Expect Business As Usual, After Whopping $805 Million Daiichi Sankyo Buyout

Mar 01 2011

• By PharmAsia News

Related Content

Amgen Takes Out Cancer Vaccine Developer BioVex In Potential $1B Deal

Jan 24 2011

Losing The Battle Of The Bulge: FDA Holds Up Orexigen's Contrave

Feb 01 2011

The $100 Million IND

Nov 01 2006

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window